(J&J recall slideshow updated with company's latest medicine recall)NEW YORK ( TheStreet) -- Medicine recalls that greatly defined Johnson & Johnson ( JNJ) last year continue to pester the company in 2011.
Tech, healthcare slide weighs on rest of markets.
Jim Cramer says it's extremely important to buy stocks that are exactly right for you and your level of risk tolerance.
Healthcare's slide weighs on rest of markets.
The days of rapid growth are far behind Japan. So can these Tokyo listings deliver as much bite as the FANGs?